The global thrombectomy devices market size reached USD 1.41 Billion in 2024. Looking forward, the market is forecast to reach USD 2.13 Billion by 2033, exhibiting a growth rate (CAGR) of 4.48% during 2025-2033. The rising preference for thrombectomy devices by surgeons to perform image-guided surgeries and continuous improvements in healthcare infrastructures are primarily propelling the market.
Thrombectomy devices offer numerous benefits in surrogate endpoints, such as biomarker analysis, infarct size reduction, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices minimize blood loss and damage caused to the vessel wall during a procedure. Consequently, they find application in treating blood clots present in veins, arteries and capillaries. They are also used to treat pulmonary embolism and peripheral arterial diseases. At present, they are widely available in different sizes and diameters, depending on the affected area. Some of the most frequently used thrombectomy devices procedures are balloon embolectomy, surgical embolectomy and aspiration embolectomy.
This report provides an analysis of the key trends in each sub-segment of the global thrombectomy devices market report, along with forecasts at the global, regional and country level from 2025-2033. The report has categorized the market based on product type, application and end user.
2. What is the expected growth rate of the global thrombectomy devices market during 2025-2033?
3. What are the key factors driving the global thrombectomy devices market?
4. What has been the impact of COVID-19 on the global thrombectomy devices market?
5. What is the breakup of the global thrombectomy devices market based on the product type?
6. What is the breakup of the global thrombectomy devices market based on the application?
7. What is the breakup of the global thrombectomy devices market based on the end user?
8. What are the key regions in the global thrombectomy devices market?
9. Who are the key players/companies in the global thrombectomy devices market?
Thrombectomy devices offer numerous benefits in surrogate endpoints, such as biomarker analysis, infarct size reduction, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices minimize blood loss and damage caused to the vessel wall during a procedure. Consequently, they find application in treating blood clots present in veins, arteries and capillaries. They are also used to treat pulmonary embolism and peripheral arterial diseases. At present, they are widely available in different sizes and diameters, depending on the affected area. Some of the most frequently used thrombectomy devices procedures are balloon embolectomy, surgical embolectomy and aspiration embolectomy.
Global Thrombectomy Devices Market Trends
According to the World Health Organization (WHO), chronic diseases are the leading causes of death and disability around the world. Disease rates from these conditions are accelerating significantly on account of hectic schedules, sedentary lifestyles, rising consumption of fast food and the increasing number of individuals who smoke and consume alcohol. This represents one of the key factors propelling the growth of the thrombectomy devices market worldwide. Moreover, the growing geriatric population, along with the escalating demand for minimally invasive (MI) procedures and improving healthcare infrastructure in various countries, is also fueling the growth of the market. Furthermore, the leading manufacturers are increasing their investments in research and development (R&D) activities to introduce technologically advanced thrombectomy devices, which, in turn, is creating a positive outlook for the market. Besides this, favorable medical reimbursements and rising preference of these devices by surgeons for performing image-guided surgeries are anticipated to strengthen the market growth.Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global thrombectomy devices market report, along with forecasts at the global, regional and country level from 2025-2033. The report has categorized the market based on product type, application and end user.Breakup by Product Type
- Aspiration Thrombectomy Devices
- Mechanical Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
- Others
Breakup by Application
- Cardiovascular
- Neurovascular
- Peripheral Vascular
Breakup by End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
Breakup by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc, Penumbra Inc., Spectranetics Corporation (Koninklijke Philips N.V.), Stryker Corporation, Teleflex Incorporated and Terumo Corporation.Key Questions Answered in This Report
1. What was the size of the global thrombectomy devices market in 2024?2. What is the expected growth rate of the global thrombectomy devices market during 2025-2033?
3. What are the key factors driving the global thrombectomy devices market?
4. What has been the impact of COVID-19 on the global thrombectomy devices market?
5. What is the breakup of the global thrombectomy devices market based on the product type?
6. What is the breakup of the global thrombectomy devices market based on the application?
7. What is the breakup of the global thrombectomy devices market based on the end user?
8. What are the key regions in the global thrombectomy devices market?
9. Who are the key players/companies in the global thrombectomy devices market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Thrombectomy Devices Market
6 Market Breakup by Product Type
7 Market Breakup by Application
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Argon Medical Devices Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Johnson & Johnson
- Medtronic Plc
- Penumbra Inc.
- Spectranetics Corporation (Koninklijke Philips N.V.)
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | February 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 1.41 Billion |
| Forecasted Market Value ( USD | $ 2.13 Billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
